CoChat

Early glycaemic control among patients with type 2 diabetes and initial glucose‐lowering treatment: a 13‐year population‐based cohort study

Thomsen, R. W., Baggesen, L. M., Svensson, E., Pedersen, L., Nørrelund, H., Buhl, E. S., Haase, C. L., Johnsen, S. P. · 2015 · Diabetes, Obesity and Metabolism
Cited by 38

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Aim: To examine real‐life time trends in early glycaemic control in patients with type 2 diabetes between 2000 and 2012. Methods: We used population‐based medical databases to ascertain the association between achievement of glycaemic control with initial glucose‐lowering treatment in patients with incident type 2 diabetes in N orthern D enmark. Success in reaching glycated haemoglobin ( HbA1c ) goals within 3–6 months was examined using regression analysis. Results: Of 38 418 patients, 91% started with oral glucose‐lowering drugs in monotherapy. Metformin initiation increased from 32% in 2000–2003 to 90% of all patients in 2010–2012. Pretreatment (interquartile range) HbA1c levels decreased from 8.9 (7.6–10.7)% in 2000–2003 to 7.0 (6.5–8.1)% in 2010–2012. More patients achieved an HbA1c target of <7% (<53 mmol/mol) in 2010–2012 than in 2000–2003 [80 vs 60%, adjusted relative risk ( aRR ) 1.10, 95% confidence interval ( CI ) 1.08–1.13], and more achieved an HbA1c target of <6.5% [(<48 mmol/mol) 53 vs 37%, aRR 1.07 95% CI 1.03–1.11)], with similar success rates observed among patients aged <65 years without comorbidities. Achieved HbA1c levels were similar for different initiation therapies, with reductions of 0.8% (from 7.3 to 6.5%) on metformin, 1.5% (from 8.1 to 6.6%) on sulphonylurea, 4.0% (from 10.4 to 6.4%) on non‐insulin combination therapies, and 3.8% (from 10.3 to 6.5%) on insulin monotherapy. Conclusions: Pretreatment HbA1c levels in patients with incident type 2 diabetes have decreased substantially, which is probably related to earlier detection and treatment in accordance with changing guidelines. Achievement of glycaemic control has improved, but 20% of patients still do not attain an HbA1c level of <7% within the first 6 months of initial treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/dom.12484

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 38

Metadata

Authors
Thomsen, R. W., Baggesen, L. M., Svensson, E., Pedersen, L., Nørrelund, H., Buhl, E. S., Haase, C. L., & Johnsen, S. P.
Venue
Diabetes, Obesity and Metabolism
Publisher
Wiley
Published
2015-06-08
Volume
17
Issue
8
Pages
771-780
ISSN
  • 1462-8902 (ISSN-L)
  • 1463-1326
OpenAlex
W1753660045
Cited by
38
References
3
FWCI
4.56
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Early glycaemic control among patients with type 2 diabetes and initial glucose‐lowering treatment: a 13‐year population‐based cohort study. https://app.cochat.ai/papers/10.1111/dom.12484
The paper
Thomsen, R. W., Baggesen, L. M., Svensson, E., Pedersen, L., Nørrelund, H., Buhl, E. S., Haase, C. L., & Johnsen, S. P. (2015). Early glycaemic control among patients with type 2 diabetes and initial glucose‐lowering treatment: a 13‐year population‐based cohort study. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.12484

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.